About: Comparison of EndoPredict and EPclin With Oncotype DX Recurrence Score for Prediction of Risk of Distant Recurrence After Endocrine Therapy.

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Comparison of EndoPredict and EPclin With Oncotype DX Recurrence Score for Prediction of Risk of Distant Recurrence After Endocrine Therapy. Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 10 July 2016

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) article scientifique (fr) artículu científicu espublizáu en 2016 (ast) наукова стаття, опублікована в липні 2016 (uk) مقالة علمية نشرت في 10 يوليو 2016 (ar) scientific article published on 10 July 2016 (en) 2016 թվականի հուլիսի 10-ին հրատարակված գիտական հոդված (hy)
publication date	wds:Q37591446-58616C12-B023-4D9C-930A-86DEC9F0C11E
publication date	2016-07-10 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q37591446-3F911B26-47C7-402C-B728-5BD400CB46EA
language of work or name	English
cites work	wds:Q37591446-2587B0E5-E0C0-45DF-95A1-663FF52B7D6A wds:Q37591446-25AEBA20-BEE5-498D-850B-0F864F2FEDD7 wds:Q37591446-29639ED6-DB78-476B-93B2-1913AD4B33B1 wds:Q37591446-2BD28F94-0B33-4D13-B7F0-F47DBD1714F4 wds:Q37591446-354EAAC6-3B97-41BF-88D2-21F4164B12F6 wds:Q37591446-3949C323-EDB1-4B37-AA82-692A3FF5D444 wds:Q37591446-5531C043-EF49-4E49-908F-7662D7D1D867 wds:Q37591446-9384779C-1481-4D4C-8A63-AA71A48D250B wds:Q37591446-93904CCD-BFCB-49BB-B346-C912BBA3B44C wds:Q37591446-9E9C028E-2CA6-4E39-98A9-A8291C787141 wds:Q37591446-A4852753-CB4D-439D-BD20-107BE11973E2 wds:Q37591446-B73443AA-12DA-4D26-80E2-B9F6A74E3452 wds:Q37591446-C3B63C50-3706-4229-A4E0-E6B572D99847 wds:Q37591446-D7D462BD-8C27-4723-8DCB-13DA9410F5D8 wds:Q37591446-ED8E37A6-C478-40BC-8E80-D5FF647B6240 wds:Q37591446-EF9B137E-20F6-45D1-8922-2F9018703749 wds:Q37591446-F2B39D32-972B-427B-AD65-49B516E6B294 wds:Q37591446-F5DA3337-62DB-44AF-BAE6-707D221D2D75
cites work	Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study population. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the Genomic Health recurrence score in early breast cancer. Factors predicting late recurrence for estrogen receptor-positive breast cancer The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2- breast cancer patients. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancer Comparison of PAM50 risk of recurrence score with oncotype DX and IHC4 for predicting risk of distant recurrence after endocrine therapy. Risk of recurrence and chemotherapy benefit for patients with node-negative, estrogen receptor-positive breast cancer: recurrence score alone and integrated with pathologic and clinical factors Prospective Validation of a 21-Gene Expression Assay in Breast Cancer Prediction of risk of distant recurrence using the 21-gene recurrence score in node-negative and node-positive postmenopausal patients with breast cancer treated with anastrozole or tamoxifen: a TransATAC study Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials A new molecular predictor of distant recurrence in ER-positive, HER2-negative breast cancer adds independent information to conventional clinical risk factors. International Web-based consultation on priorities for translational breast cancer research Prognostic utility of HOXB13:IL17BR and molecular grade index in early-stage breast cancer patients from the Stockholm trial Decentral gene expression analysis for ER+/Her2- breast cancer: results of a proficiency testing program for the EndoPredict assay Forest plots and the interpretation of subgroups Estrogen Receptor Expression in 21-Gene Recurrence Score Predicts Increased Late Recurrence for Estrogen-Positive/HER2-Negative Breast Cancer
author name string	wds:Q37591446-20F57FF5-F272-48BD-9F1B-61CAF135B5E0 wds:Q37591446-36E2FAE8-1CBD-4B35-B06E-9BD2F22EAE5E wds:Q37591446-9EA96F8A-AC14-4A8F-9145-6C910CFB690E wds:Q37591446-A7D4F88B-0134-4D78-86FE-B992E125734A wds:Q37591446-BDA8D4DB-7420-4CD1-861A-81FB3D786B80 wds:Q37591446-E130B3F5-72FC-4052-8C2B-4E524A3AA05E
author name string	Peter Dubsky Ralf Kronenwett Christoph Petry Ivana Sestak Kristin Krappmann Marsel Scheer
rdfs:label	Comparison of EndoPredict and EPclin With Oncotype DX Recurrence Score for Prediction of Risk of Distant Recurrence After Endocrine Therapy. (en) Comparison of EndoPredict and EPclin With Oncotype DX Recurrence Score for Prediction of Risk of Distant Recurrence After Endocrine Therapy. (nl) Comparison of EndoPredict and EPclin With Oncotype DX Recurrence Score for Prediction of Risk of Distant Recurrence After Endocrine Therapy. (ast)
skos:prefLabel	Comparison of EndoPredict and EPclin With Oncotype DX Recurrence Score for Prediction of Risk of Distant Recurrence After Endocrine Therapy. (en) Comparison of EndoPredict and EPclin With Oncotype DX Recurrence Score for Prediction of Risk of Distant Recurrence After Endocrine Therapy. (nl) Comparison of EndoPredict and EPclin With Oncotype DX Recurrence Score for Prediction of Risk of Distant Recurrence After Endocrine Therapy. (ast)
name	Comparison of EndoPredict and EPclin With Oncotype DX Recurrence Score for Prediction of Risk of Distant Recurrence After Endocrine Therapy. (en) Comparison of EndoPredict and EPclin With Oncotype DX Recurrence Score for Prediction of Risk of Distant Recurrence After Endocrine Therapy. (nl) Comparison of EndoPredict and EPclin With Oncotype DX Recurrence Score for Prediction of Risk of Distant Recurrence After Endocrine Therapy. (ast)
author	wds:Q37591446-2ED58FA8-68AA-4ED0-A041-807A988B4C3E wds:Q37591446-696AF4BF-84CC-47CB-8503-3432D71CAFC7 wds:Q37591446-749F4E94-0EB8-47A1-A8B9-CE472EE8C462 wds:Q37591446-E83C48FE-D245-49C3-BD7A-8D78D9393990
author	Jack Cuzick Carsten Denkert Mitch Dowsett Richard Buus
title	wds:Q37591446-9673772B-47D9-449D-B34B-C1AEBCA6973B
title	Comparison of EndoPredict and EPclin With Oncotype DX Recurrence Score for Prediction of Risk of Distant Recurrence After Endocrine Therapy (en)
instance of	wds:Q37591446-98EFE3DC-E5F9-425F-8E27-634411190D22
instance of	scholarly article
PubMed ID	wds:Q37591446-8361894A-E2BF-48DC-BABE-47736B5AD2F0
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/27400969
PubMed ID	27400969
published in	wds:Q37591446-6D8638EC-4E4F-467A-BD06-5275C2CF52A4
published in	Journal of the National Cancer Institute
issue	wds:Q37591446-CE21CB1C-CAF8-44C8-851F-CFFA8BE6E56C
volume	wds:Q37591446-F4A26BE4-D551-4044-81AE-70498C64D607
issue	11
volume	108

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software